Epitope-specific changes in chondroitin sulfate/dermatan sulfate proteoglycans as markers in the lymphopoietic and granulopoietic compartments of developing bursae of Fabricius.
The types and distributions of chondroitin sulfate proteoglycans within developing chick bursae of Fabricius were determined by indirect immunocytochemical analyses using mAb specific for chondroitin/dermatan sulfate epitopes. Analyses obtained from the use of well characterized mAb known to specifically identify chondroitin 4- and dermatan sulfates (antibody 2B6) and chondroitin 6-sulfate (antibody 3B3) were compared with those obtained from two additional mAb raised against chick chondroitin sulfates proteoglycans derived from hemopoietic tissue. The results indicate that chondroitin sulfate compositions of the adjacent lymphopoietic and granulopoietic compartments differ. Chondroitin 6-sulfate, notably absent from lymphopoietic regions, is a major chondroitin sulfate species in granulopoietic regions of day 13 bursae. Moreover, chondroitin 6-sulfate disappears from the granulopoietic compartment in a time course that corresponds to the decline in granulopoietic activity. Simultaneously, there is an apparent increase in chondroitin sulfates associated with developing medullary regions of lymphoid follicles. The content of chondroitin 4-/dermatan sulfates and, most significantly, of chondroitin/dermatan sulfates identified by antibodies raised against chick proteoglycans, increases within developing follicles. As a consequence, by day 18 of incubation, immunostained follicles become clearly demarcated from the connective tissue of the tunica propria. This study provides evidence that chondroitin sulfates are constituents of both lymphopoietic and granulopoietic microenvironments and that subtle changes occur within these proteoglycan structures during bursal development. These developmental changes in chondroitin sulfate compositions are consistent with these molecules playing a functional role in hemopoiesis.
D000818:Animals; D000918:Antibody Specificity; D002060:Bursa of Fabricius / Q000166:cytology* / Q000254:growth & development / Q000276:immunology; D002642:Chick Embryo; D002807:Chondroitin / Q000031:analogs & derivatives*; D011508:Chondroitin Sulfate Proteoglycans / Q000276:immunology*; D002809:Chondroitin Sulfates / Q000276:immunology*; D003871:Dermatan Sulfate / Q000276:immunology*; D004848:Epithelium / Q000276:immunology; D000939:Epitopes / Q000032:analysis*; D006025:Glycosaminoglycans / Q000276:immunology; D006098:Granulocytes / Q000276:immunology / Q000502:physiology; D006412:Hematopoietic Stem Cells / Q000276:immunology* / Q000502:physiology; D008214:Lymphocytes / Q000276:immunology / Q000502:physiology; D011509:Proteoglycans / Q000276:immunology*
D011508:Chondroitin Sulfate Proteoglycans; D000939:Epitopes; D006025:Glycosaminoglycans; D011509:Proteoglycans; D003871:Dermatan Sulfate; D002807:Chondroitin; D002809:Chondroitin Sulfates